Inhibitor of topoisomerase II with anti-neoplastic activity. The compound interferes with the topoisomerase II-mediated repair of DNA causing accumulation of mutations. Doxorubicin also leads to the generation of reactive oxygen species (ROS), which further damage DNA as well as proteins and membranes. However, the compound presents with a risk of developing cardiomyopathy as well as drug resistance.
Price on application.
+44 (0)1635 578444
+41 (0)71 858 2020
+421 (0)22 102 5699
+86 512 6260 5585
+91 44 4201 6316
For requirements greater than the catalogue prepacks email: firstname.lastname@example.org
For custom synthesis or special requests email: email@example.com, call +44 (0)1635 578444 or fill out our contact form
To order this product please fill out our contact form, email firstname.lastname@example.org
This product is restricted and not available to purchase online.
Please contact us at email@example.com and we will confirm what documentation and/or licences are required prior to any sale.